Galmed Pharmaceuticals Stock Price Prediction
| GLMD Stock | USD 2.94 0.08 2.80% |
Oversold Vs Overbought
43
Oversold | Overbought |
Wall Street Target Price 12 |
Using Galmed Pharmaceuticals hype-based prediction, you can estimate the value of Galmed Pharmaceuticals from the perspective of Galmed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Galmed Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Galmed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Galmed Pharmaceuticals after-hype prediction price | USD 2.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Galmed |
Galmed Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Galmed Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Galmed Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Galmed Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Galmed Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Galmed Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Galmed Pharmaceuticals' historical news coverage. Galmed Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.11 and 40.09, respectively. We have considered Galmed Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Galmed Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Galmed Pharmaceuticals is based on 3 months time horizon.
Galmed Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Galmed Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Galmed Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Galmed Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.14 | 37.86 | 4.02 | 0.75 | 5 Events / Month | 4 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.94 | 2.23 | 24.15 |
|
Galmed Pharmaceuticals Hype Timeline
Galmed Pharmaceuticals is currently traded for 2.94. The entity has historical hype elasticity of -4.02, and average elasticity to hype of competition of 0.75. Galmed is expected to decline in value after the next headline, with the price expected to drop to 2.23. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -24.15%, whereas the daily expected return is currently at 3.14%. The volatility of related hype on Galmed Pharmaceuticals is about 15836.27%, with the expected price after the next announcement by competition of 3.69. The company has price-to-book (P/B) ratio of 0.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Galmed Pharmaceuticals recorded earning per share (EPS) of 69.72. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 30th of August 2024. Given the investment horizon of 90 days the next expected press release will be in about 5 days. Check out Galmed Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Galmed Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Galmed Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Galmed Pharmaceuticals' future price movements. Getting to know how Galmed Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Galmed Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CADL | Candel Therapeutics | (0.05) | 9 per month | 0.00 | (0.11) | 6.70 | (5.78) | 26.59 | |
| CINGW | Cingulate Warrants | 0.01 | 1 per month | 13.29 | 0.06 | 36.81 | (26.16) | 95.43 | |
| UNCY | Unicycive Therapeutics | (0.05) | 7 per month | 4.12 | 0.22 | 10.26 | (7.32) | 29.22 | |
| CDIO | Cardio Diagnostics Holdings | (0.01) | 3 per month | 6.69 | (0.01) | 14.81 | (13.16) | 57.04 | |
| VRAX | Virax Biolabs Group | (0.81) | 3 per month | 0.00 | (0.13) | 9.65 | (12.90) | 61.28 | |
| SNTI | Senti Biosciences | 2.91 | 2 per month | 3.42 | 0.11 | 7.35 | (7.36) | 29.17 | |
| CVKD | Cadrenal Therapeutics, Common | (0.33) | 9 per month | 6.02 | 0.16 | 17.85 | (9.54) | 47.47 |
Galmed Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Galmed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Galmed using various technical indicators. When you analyze Galmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Galmed Pharmaceuticals Predictive Indicators
The successful prediction of Galmed Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Galmed Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Galmed Pharmaceuticals based on analysis of Galmed Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Galmed Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Galmed Pharmaceuticals's related companies. | 2023 | 2024 (projected) | Graham Number | 202.0 | 212.1 | Receivables Turnover | 35.96 | 37.76 |
Story Coverage note for Galmed Pharmaceuticals
The number of cover stories for Galmed Pharmaceuticals depends on current market conditions and Galmed Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Galmed Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Galmed Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Galmed Pharmaceuticals Short Properties
Galmed Pharmaceuticals' future price predictability will typically decrease when Galmed Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Galmed Pharmaceuticals often depends not only on the future outlook of the potential Galmed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galmed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 230.8 K | |
| Cash And Short Term Investments | 12.6 M |
Complementary Tools for Galmed Stock analysis
When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance |